Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
34 participants
INTERVENTIONAL
2021-12-20
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants:
Thirty-four patients of both genders will be selected through non-probability sampling diagnosed as Neer's stage II SIS and their age range from 25-45 years will be randomly assigned to 1 of 2 groups. Each patient will sign an informed consent before starting the study (Appendix III).
Eligible patients will be recruited by physical therapist via referral from the treating orthopedic surgeon who will diagnose SIS based on clinical and radiological examination.
Group I (control): it includes 17 patients who will receive traditional strength training program.
Group II (experimental): it includes 17 patients who will receive upper extremity neuromuscular training exercises
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I (control)
: it includes 17 patients who will receive traditional strength training program.
traditional training exerises
traditional strength training exercises in group I
Group II (experimental):
it includes 17 patients who will receive upper extremity neuromuscular training exercises
NEUROMUSCULAR TRAINING EXERCISE
patients will receive neuromuscular training exercises in group II
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NEUROMUSCULAR TRAINING EXERCISE
patients will receive neuromuscular training exercises in group II
traditional training exerises
traditional strength training exercises in group I
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Shoulder pain for at least three months (Heron et al., 2017) Painful arc of movement during flexion or abduction (Heron et al., 2017). Positive Neer's or Kennedy- Hawkins Test (Heron et al., 2017). Pain on resisted external rotation, abduction or Empty Can Test (Ager et al., 2019).
Exclusion Criteria
:
25 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aya Ahmed Elnour Noaman Nada
researcher
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
maha mostafa mohammed, associate professor
Role: CONTACT
Phone: +201118803232
Email: [email protected]
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
shoulder neuromuscular
Identifier Type: -
Identifier Source: org_study_id